These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. 2-Amino metabolites are key mediators of CB 1954 and SN 23862 bystander effects in nitroreductase GDEPT. Helsby NA; Ferry DM; Patterson AV; Pullen SM; Wilson WR Br J Cancer; 2004 Mar; 90(5):1084-92. PubMed ID: 14997211 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationships for 2,4-dinitrobenzamide-5-mustards as prodrugs for the Escherichia coli nfsB nitroreductase in gene therapy. Atwell GJ; Yang S; Pruijn FB; Pullen SM; Hogg A; Patterson AV; Wilson WR; Denny WA J Med Chem; 2007 Mar; 50(6):1197-212. PubMed ID: 17326614 [TBL] [Abstract][Full Text] [Related]
4. Aziridinyldinitrobenzamides: synthesis and structure-activity relationships for activation by E. coli nitroreductase. Helsby NA; Atwell GJ; Yang S; Palmer BD; Anderson RF; Pullen SM; Ferry DM; Hogg A; Wilson WR; Denny WA J Med Chem; 2004 Jun; 47(12):3295-307. PubMed ID: 15163209 [TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships for 4-nitrobenzyl carbamates of 5-aminobenz[e]indoline minor groove alkylating agents as prodrugs for GDEPT in conjunction with E. coli nitroreductase. Hay MP; Atwell GJ; Wilson WR; Pullen SM; Denny WA J Med Chem; 2003 Jun; 46(12):2456-66. PubMed ID: 12773049 [TBL] [Abstract][Full Text] [Related]
6. Nitroarylmethylcarbamate prodrugs of doxorubicin for use with nitroreductase gene-directed enzyme prodrug therapy. Hay MP; Wilson WR; Denny WA Bioorg Med Chem; 2005 Jun; 13(12):4043-55. PubMed ID: 15911317 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of nitroheterocyclic carbamate prodrugs for use with nitroreductase-mediated gene-directed enzyme prodrug therapy. Hay MP; Anderson RF; Ferry DM; Wilson WR; Denny WA J Med Chem; 2003 Dec; 46(25):5533-45. PubMed ID: 14640560 [TBL] [Abstract][Full Text] [Related]
8. Studies on the nitroreductase prodrug-activating system. Crystal structures of complexes with the inhibitor dicoumarol and dinitrobenzamide prodrugs and of the enzyme active form. Johansson E; Parkinson GN; Denny WA; Neidle S J Med Chem; 2003 Sep; 46(19):4009-20. PubMed ID: 12954054 [TBL] [Abstract][Full Text] [Related]
9. Nitrobenzyl carbamate prodrugs of enediynes for nitroreductase gene-directed enzyme prodrug therapy (GDEPT). Hay MP; Wilson WR; Denny WA Bioorg Med Chem Lett; 1999 Dec; 9(24):3417-22. PubMed ID: 10617083 [TBL] [Abstract][Full Text] [Related]
10. The bystander effect of the nitroreductase/CB1954 enzyme/prodrug system is due to a cell-permeable metabolite. Bridgewater JA; Knox RJ; Pitts JD; Collins MK; Springer CJ Hum Gene Ther; 1997 Apr; 8(6):709-17. PubMed ID: 9113510 [TBL] [Abstract][Full Text] [Related]
11. Bioactivation of dinitrobenzamide mustards by an E. coli B nitroreductase. Anlezark GM; Melton RG; Sherwood RF; Wilson WR; Denny WA; Palmer BD; Knox RJ; Friedlos F; Williams A Biochem Pharmacol; 1995 Aug; 50(5):609-18. PubMed ID: 7669063 [TBL] [Abstract][Full Text] [Related]
12. Quantitation of bystander effects in nitroreductase suicide gene therapy using three-dimensional cell cultures. Wilson WR; Pullen SM; Hogg A; Helsby NA; Hicks KO; Denny WA Cancer Res; 2002 Mar; 62(5):1425-32. PubMed ID: 11888915 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological evaluation of cyclic and acyclic nitrobenzylphosphoramide mustards for E. coli nitroreductase activation. Jiang Y; Han J; Yu C; Vass SO; Searle PF; Browne P; Knox RJ; Hu L J Med Chem; 2006 Jul; 49(14):4333-43. PubMed ID: 16821793 [TBL] [Abstract][Full Text] [Related]
14. Discovery and evaluation of Escherichia coli nitroreductases that activate the anti-cancer prodrug CB1954. Prosser GA; Copp JN; Syddall SP; Williams EM; Smaill JB; Wilson WR; Patterson AV; Ackerley DF Biochem Pharmacol; 2010 Mar; 79(5):678-87. PubMed ID: 19852945 [TBL] [Abstract][Full Text] [Related]
15. Repurposing Ruiz de Garibay G; García de Jalón E; Stigen E; Lund KB; Popa M; Davidson B; Safont MM; Rygh CB; Espedal H; Barrett TM; Haug BE; McCormack E Theranostics; 2021; 11(12):6044-6057. PubMed ID: 33897898 [TBL] [Abstract][Full Text] [Related]
16. Noninvasive optical imaging of nitroreductase gene-directed enzyme prodrug therapy system in living animals. Bhaumik S; Sekar TV; Depuy J; Klimash J; Paulmurugan R Gene Ther; 2012 Mar; 19(3):295-302. PubMed ID: 21753794 [TBL] [Abstract][Full Text] [Related]
17. Delivery of the bacterial nitroreductase gene into endothelial cells prolongs the survival of tumour-bearing mice by bystander mechanisms. Benouchan M; Do Nascimento F; Perret GY; Colombo BM Int J Oncol; 2006 Feb; 28(2):457-62. PubMed ID: 16391801 [TBL] [Abstract][Full Text] [Related]
18. E. coli nitroreductase/CB1954 gene-directed enzyme prodrug therapy: role of arylamine N-acetlytransferase 2. Mitchell DJ; Minchin RF Cancer Gene Ther; 2008 Nov; 15(11):758-64. PubMed ID: 18600257 [TBL] [Abstract][Full Text] [Related]
19. Evaluating the abilities of diverse nitroaromatic prodrug metabolites to exit a model Gram negative vector for bacterial-directed enzyme-prodrug therapy. Chan-Hyams JVE; Copp JN; Smaill JB; Patterson AV; Ackerley DF Biochem Pharmacol; 2018 Dec; 158():192-200. PubMed ID: 30352235 [TBL] [Abstract][Full Text] [Related]
20. The nitroreductase prodrug SN 28343 enhances the potency of systemically administered armed oncolytic adenovirus ONYX-411(NTR). Singleton DC; Li D; Bai SY; Syddall SP; Smaill JB; Shen Y; Denny WA; Wilson WR; Patterson AV Cancer Gene Ther; 2007 Dec; 14(12):953-67. PubMed ID: 17975564 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]